VRTX Vertex Pharmaceuticals Inc

343.845
-3.99 (-1.15%)
Last Updated: 12:32:47
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Company Name Stock Ticker Symbol Market Type
Vertex Pharmaceuticals Inc VRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-3.99 -1.15% 343.845 12:32:47
Open Price Low Price High Price Close Price Prev Close
345.28 341.85 347.79 347.83
more quote information »

Recent News

Date Time Source Heading
10/03/20238:50IHNWFeaturedCannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath
10/03/202311:11EDGAR2Form 144 - Report of proposed sale of securities
10/02/202312:34EDGAR2Form 144 - Report of proposed sale of securities
9/21/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/19/202309:55EDGAR2Form 144 - Report of proposed sale of securities
9/15/202309:39DJNVertex Pharmaceuticals Gets European Regulators' Nod for..
9/15/202308:52BWVertex Receives CHMP Positive Opinion for KAFTRIO®..
9/14/202309:15BWVertex Researchers Awarded 2024 Breakthrough Prize in Life..
9/07/202316:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202316:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/05/202315:03EDGAR2Form 144 - Report of proposed sale of securities
8/30/202316:01BWVertex to Participate in the Morgan Stanley 21st Annual..
8/29/202309:00BWVertex Appoints E. Morrey Atkinson, Ph.D., to EVP and Chief..
8/25/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/23/202312:37EDGAR2Form 144 - Report of proposed sale of securities
8/14/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/11/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/11/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202313:50EDGAR2Form 144 - Report of proposed sale of securities
8/10/202313:07EDGAR2Form 144 - Report of proposed sale of securities
8/10/202310:47EDGAR2Form 144 - Report of proposed sale of securities
8/09/202312:04EDGAR2Form 144 - Report of proposed sale of securities
8/09/202310:14EDGAR2Form 144 - Report of proposed sale of securities
8/03/202308:00BWVertex Announces Publication of VX-548 Positive Phase 2,..
8/02/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/01/202316:48DJNVertex Pharmaceuticals 2Q Profit Up On Higher Cystic..
8/01/202316:03EDGAR2Form 8-K - Current report
8/01/202316:01BWVertex Reports Second Quarter 2023 Financial Results
7/18/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202316:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/17/202313:40EDGAR2Form 144 - Report of proposed sale of securities
7/17/202312:26EDGAR2Form 144 - Report of proposed sale of securities
7/05/202303:00BWEuropean Commission Approves ORKAMBI® (lumacaftor/ivacaftor)..
6/30/202308:01BWVertex to Announce Second Quarter 2023 Financial Results on..
6/26/202307:30BWVertex and Lonza to Build Dedicated Manufacturing Facility..
6/23/202318:55BWVertex Presents Positive VX-880 Results From Ongoing Phase..
6/09/202311:00BWVertex Presents Data Demonstrating Significant Benefits of..
6/09/202303:01BWPositive Results From Pivotal Trials of exa-cel for..
6/08/202319:23BWFDA Accepts Biologics License Applications for exagamglogene..
5/30/202308:01BWVertex to Participate in the Goldman Sachs 44th Annual..
5/05/202312:05DJNVertex Pharmaceuticals On Pace for Record High Close -- Data..
5/03/202317:07BWVertex Announces U.S. FDA Approval for KALYDECO® (ivacaftor)..
5/01/202316:48DJNVertex Pharmaceuticals 1Q Net Down On Higher Costs
5/01/202316:01BWVertex Reports First Quarter 2023 Financial Results
4/27/202302:00BWVertex Receives CHMP Positive Opinion for ORKAMBI®..
4/26/202314:33DJNVertex: FDA OKs Trikafta for Some Children Ages 2 Through 5..
4/26/202313:37BWVertex Announces U.S. FDA Approval for TRIKAFTA®..
4/25/202308:01BWVertex to Present at the Bank of America Securities 2023..
Your Recent History
NASDAQ
VRTX
Vertex Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now